Evidence map›Paper›PMID 32824188›Full record

ArticleInternational journal of molecular sciences2020

NanoBiT System and Hydrofurimazine for Optimized Detection of Viral Infection in Mice-A Novel in Vivo Imaging Platform.

Natasa Gaspar, Giorgia Zambito, Iris J C Dautzenberg, Steve J Cramer, Rob C Hoeben, Clemens Lowik, Joel R Walker, Thomas A Kirkland, Thomas P Smith, Wytske M van Weerden and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Intracellular Ionic Strength Sensing Using NanoLuc.International journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Natasa GasparDepartment of Radiology and Nuclear Medicine, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
Giorgia ZambitoDepartment of Radiology and Nuclear Medicine, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
Iris J C DautzenbergLeiden University Medical Center, Department of Cell and Chemical Biology, 2333 Leiden, The Netherlands.
Steve J CramerLeiden University Medical Center, Department of Cell and Chemical Biology, 2333 Leiden, The Netherlands.
Rob C HoebenLeiden University Medical Center, Department of Cell and Chemical Biology, 2333 Leiden, The Netherlands.
Clemens LowikDepartment of Radiology and Nuclear Medicine, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0003-0859-5785
Joel R WalkerPromega Biosciences L.L.C., San Luis Obispo, CA 93401, USA.
Thomas A KirklandPromega Biosciences L.L.C., San Luis Obispo, CA 93401, USA.ORCID 0000-0003-0324-4804
Thomas P SmithPromega Biosciences L.L.C., San Luis Obispo, CA 93401, USA.ORCID 0000-0002-1381-9360
Wytske M van WeerdenErasmus Medical Center, Department of Urology, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0001-9443-8377
Jeroen de VrijErasmus Medical Center, Department of Neurosurgery, 3015 GD Rotterdam, The Netherlands.
Laura MezzanotteDepartment of Radiology and Nuclear Medicine, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
Erasmus MC · NLLeiden University Medical Center · NLPromega (United States) · US

Funding

European Commission 675743European Commission 777682
6 · The paper itself

Abstract

Reporter genes are used to visualize intracellular biological phenomena, including viral infection. Here we demonstrate bioluminescent imaging of viral infection using the NanoBiT system in combination with intraperitoneal injection of a furimazine analogue, hydrofurimazine. This recently developed substrate has enhanced aqueous solubility allowing delivery of higher doses for in vivo imaging. The small high-affinity peptide tag (HiBiT), which is only 11 amino-acids in length, was engineered into a clinically used oncolytic adenovirus, and the complementary large protein (LgBiT) was constitutively expressed in tumor cells. Infection of the LgBiT expressing cells with the HiBiT oncolytic virus will reconstitute NanoLuc in the cytosol of the cell, providing strong bioluminescence upon treatment with substrate. This new bioluminescent system served as an early stage quantitative viral transduction reporter in vitro and also in vivo in mice, for longitudinal monitoring of oncolytic viral persistence in infected tumor cells. This platform provides novel opportunities for studying the biology of viruses in animal models.

Indexed as

AdenoviridaeAnimalsCell Line, TumorFuransHEK293 CellsHumansImidazolesInjections, IntraperitonealLuminescent AgentsLuminescent ProteinsMaleMiceMice, Inbred BALB CMice, NudeOligopeptidesOncolytic VirusesFuransfurimazineImidazolesLuminescent AgentsLuminescent ProteinsOligopeptidesPyrazinesRecombinant Proteinsbioluminescence imaginghibit taghydrofurimazinenanobit systemoncolytic virus

Identifiers

PMID32824188
PMCPMC7461499
OpenAlexW3049100819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.